MERIFIDE Trademark

Trademark Overview

On Monday, September 16, 2013, a trademark application was filed for MERIFIDE with the United States Patent and Trademark Office. The USPTO has given the MERIFIDE trademark a serial number of 86065285. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 19, 2021. This trademark is owned by Sanofi. The MERIFIDE trademark is filed in the Pharmaceutical Products category with the following description:

Cardiovascular pharmaceuticals
merifide

General Information

Serial Number86065285
Word MarkMERIFIDE
Filing DateMonday, September 16, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 19, 2021
Registration Number4583126
Registration DateTuesday, August 12, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 27, 2014

Trademark Statements

Goods and ServicesCardiovascular pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSANOFI BIOTECHNOLOGY
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
Address75008 PARIS
FR
Party NameSanofi
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressParis 75008
FR
Party NameSanofi
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParis 75008
FR
Party NameSanofi
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParis 75008
FR

Trademark Events

Event DateEvent Description
Friday, March 19, 2021CANCELLED SEC. 8 (6-YR)
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 12, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 14, 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 12, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, May 27, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 27, 2014PUBLISHED FOR OPPOSITION
Wednesday, May 7, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 21, 2014NOTICE OF ALLOWANCE CANCELLED
Tuesday, April 15, 2014ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Tuesday, April 15, 2014PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, April 10, 2014ASSIGNED TO PETITION STAFF
Monday, April 7, 2014TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, January 28, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 3, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2013PUBLISHED FOR OPPOSITION
Wednesday, November 13, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 29, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 29, 2013ASSIGNED TO EXAMINER
Monday, September 23, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 19, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

merifide pharmaceuticals cardiovascular